Tag Archives: Cardiovascular Disease
Effect of the SGLT2 inhibitor dapagliflozin on total body weight and systolic blood pressure in patients with type 2 diabetes mellitus on metformin. When added to background metformin therapy, dapagliflozin induced early effects on total body weight (A) and systolic blood pressure (B) that were sustained over 4 years of treatment.43 Copyright © 2015 John Wiley & Sons.

Novel and Emerging Therapeutics for Primary Prevention of Cardiovascular Disease

Cardiovascular disease is responsible for 205 deaths per 100,000 persons annually and is the leading cause of death worldwide. The public health burden of cardiovascular disease is expected to continue to grow as the prevalence of many cardiovascular risk factors increases. Several novel classes of glucose-lowering, lipid-lowering, and weight-loss therapeutics have shown mortality benefits in […]

Read more
doctor-cardiogram-stock

Sustained Socioeconomic Inequalities in Hospital Admissions for Cardiovascular Events Among People with Diabetes in England

This study aimed to determine changes in absolute and relative socioeconomic inequalities in hospital admissions for major cardiovascular causes among patients with diabetes in England. Methods We identified all patients with diabetes aged ≥45 years admitted to the hospital in England between 2004-2005 and 2014-2015 for acute myocardial infarction, stroke, percutaneous coronary intervention, or coronary […]

Read more
doctor shaking hands with female patient

Coaching Patients Saves Lives and Money

The Coaching On Achieving Cardiovascular Health (COACH) Program has been proven to improve biomedical and lifestyle cardiovascular disease (CVD) risk factors. The objective of this study was to evaluate the long-term impact of The COACH Program on overall survival, hospital utilization, and costs from the perspective of a private health insurer (payor), in patients with […]

Read more
Global mortality rates in males due to cardiovascular disease; originally published jointly by the World Health Organization in collaboration with the World Heart Federation and World Stroke Organization in 2011 as part of the Global Atlas On Cardiovascular Disease Prevention and Control; permission granted by World Heart Federation, November 14, 2017 and World Health Organization, November 23, 2017 (Permission access number 243602).

The Deficit of Nutrition Education of Physicians

Globally, death rates from cardiovascular disease are increasing, rising 41% between 1990 and 2013, and are often attributed, at least in part, to poor diet quality. With urbanization, economic development, and mass marketing, global dietary patterns have become more Westernized to include more sugar-sweetened beverages, highly processed foods, animal-based foods, and fewer fruits and vegetables, […]

Read more
glowing-heart-stock

Personalized Activity Intelligence (PAI) for Prevention of Cardiovascular Disease

To derive and validate a single metric of activity tracking that associates with lower risk of cardiovascular disease mortality. Methods We derived an algorithm, Personalized Activity Intelligence (PAI), using the HUNT Fitness Study (n = 4631), and validated it in the general HUNT population (n = 39,298) aged 20-74 years. The PAI was divided into three sex-specific […]

Read more
Risk of bias assessment of the included randomized controlled trials using the Cochrane Risk of Bias Tool.

Cardiovascular Risks of Exogenous Testosterone Use Among Men (videos)

We sought to evaluate whether exogenous testosterone therapy is associated with increased risk of serious cardiovascular events as compared with other treatments or placebo. Methods Study selection included randomized controlled trials (RCTs) and observational studies that enrolled men aged 18 years or older receiving exogenous testosterone for 3 or more days. The primary outcomes were […]

Read more
UA-42320404-1